{"id":"https://openalex.org/W2183108780","doi":null,"title":"17-Aza Steroids as 5\u03b1-Reductase Inhibitors: A Review","display_name":"17-Aza Steroids as 5\u03b1-Reductase Inhibitors: A Review","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2183108780","mag":"2183108780"},"language":"en","primary_location":{"id":"mag:2183108780","doi":null,"is_oa":false,"landing_page_url":"http://ijppr.com/PDF/5/IJPPR,Vol5,Issue2,Article10.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"review","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110126630","display_name":"Manav Malhotra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manav Malhotra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050175716","display_name":"Richa Dhingra","orcid":"https://orcid.org/0000-0003-1024-5338","observed_orcids":["https://orcid.org/0000-0003-1024-5338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richa Dhingra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1024-5338","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012622153","display_name":"Rajiv Kumar Sharma","orcid":"https://orcid.org/0000-0002-1905-0986","observed_orcids":["https://orcid.org/0000-0002-1905-0986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajiv Sharma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1905-0986","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0554,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.06437768,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5alpha-reductase-inhibitors","display_name":"5-alpha reductase inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dihydrotestosterone","display_name":"dihydrotestosterone","score":0.9509999752044678},{"id":"https://openalex.org/keywords/secosteroids","display_name":"secosteroids","score":0.8410000205039978},{"id":"https://openalex.org/keywords/lower-urinary-tract-symptoms","display_name":"lower urinary tract symptoms","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.7981094717979431},{"id":"https://openalex.org/C2779881493","wikidata":"https://www.wikidata.org/wiki/Q411054","display_name":"Dihydrotestosterone","level":4,"score":0.6599065661430359},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5696612000465393},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5553139448165894},{"id":"https://openalex.org/C2779478474","wikidata":"https://www.wikidata.org/wiki/Q446372","display_name":"Lower urinary tract symptoms","level":4,"score":0.5394448041915894},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.42116838693618774},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.41863587498664856},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36956900358200073},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36565154790878296},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3275250196456909},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3066723942756653},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.28513067960739136},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17746326327323914},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.12563735246658325},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.08906161785125732}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2183108780","doi":null,"is_oa":false,"landing_page_url":"http://ijppr.com/PDF/5/IJPPR,Vol5,Issue2,Article10.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W141806486","https://openalex.org/W198934061","https://openalex.org/W1975056461","https://openalex.org/W1979677964","https://openalex.org/W1980752196","https://openalex.org/W1982159915","https://openalex.org/W1987032701","https://openalex.org/W1988467487","https://openalex.org/W1988976487","https://openalex.org/W1992163721","https://openalex.org/W1993339135","https://openalex.org/W1996943749","https://openalex.org/W1997763059","https://openalex.org/W2003678448","https://openalex.org/W2017210216","https://openalex.org/W2017567105","https://openalex.org/W2022065845","https://openalex.org/W2022147624","https://openalex.org/W2027588860","https://openalex.org/W2029877275","https://openalex.org/W2030928575","https://openalex.org/W2037832686","https://openalex.org/W2038679453","https://openalex.org/W2041624897","https://openalex.org/W2045090671","https://openalex.org/W2051845929","https://openalex.org/W2053197788","https://openalex.org/W2054642769","https://openalex.org/W2057001056","https://openalex.org/W2062166495","https://openalex.org/W2071764284","https://openalex.org/W2074235784","https://openalex.org/W2082969011","https://openalex.org/W2104155137","https://openalex.org/W2104494651","https://openalex.org/W2119667665","https://openalex.org/W2126351285","https://openalex.org/W2142103310","https://openalex.org/W2143507187","https://openalex.org/W2146451037","https://openalex.org/W2154343412","https://openalex.org/W2186652366","https://openalex.org/W2271693156","https://openalex.org/W2327030580","https://openalex.org/W2328495219","https://openalex.org/W2442648637","https://openalex.org/W2950027717","https://openalex.org/W2950574646","https://openalex.org/W2950661731","https://openalex.org/W2953118959"],"related_works":["https://openalex.org/W2068061050","https://openalex.org/W2080264705","https://openalex.org/W2021424019","https://openalex.org/W2271693156","https://openalex.org/W81210875","https://openalex.org/W2372302498","https://openalex.org/W1999962914","https://openalex.org/W1966337486","https://openalex.org/W2041893439","https://openalex.org/W1964928662"],"abstract_inverted_index":{"aza":[0],"steroids":[1,95,119],"are":[2],"the":[3,13,23,35,39,50,54,84,93,99],"important":[4],"class":[5],"of":[6,15,25,41,53,86],"compounds":[7],"used":[8],"as":[9,70,121],"5\u03b1-reductase":[10],"inhibitors":[11],"for":[12,38],"treatment":[14],"benign":[16,42,59],"prostatic":[17,43,46,60],"hyperplasia.":[18,44],"As":[19],"these":[20],"agents":[21],"blocks":[22],"conversion":[24],"Tes":[26],"tosterone":[27],"(T)":[28],"into":[29],"Dihydrotestosterone":[30],"(D":[31],"HT)":[32],"which":[33],"is":[34,49,96],"main":[36],"reason":[37],"development":[40],"Benign":[45],"hyperplasia":[47],"(BPH)":[48],"noncancerous":[51],"proliferation":[52],"prostate":[55],"gland":[56],"associated":[57],"with":[58,78],"obstructi":[61],"on":[62],"and":[63,73,129],"lower":[64],"urinary":[65],"tract":[66],"symptoms":[67],"(LUTS)":[68],"such":[69,120],"frequency,":[71],"hesitancy":[72],"urgency.":[74],"Its":[75],"prevalence":[76],"increases":[77],"age":[79,85],"affecting":[80],"around":[81],"70%":[82],"by":[83,108],"70":[87],"years.":[88],"Main":[89],"attention":[90],"given":[91],"to":[92,98],"17-aza":[94],"due":[97],"back":[100],"binding":[101],"or":[102],"inverted":[103],"action":[104],"that":[105],"was":[106],"proposed":[107],"Mac":[109],"Donald":[110],"et":[111],"al.":[112],"In":[113],"this":[114],"review,":[115],"different":[116],"17":[117],"-aza":[118],"seco-steroids,":[122],"alkyl":[123],"chain":[124],"derivates":[125],"at":[126],"17-position,":[127],"3\u03b2-esters":[128],"many":[130],"other":[131],"derivatives":[132],"were":[133],"shown.":[134]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}